Khaled Greish is a Professor in Nanomedicine at the Department of Molecular Medicine, Faculty of Medicine and Medical Sciences, Arabian Gulf University. He also serves as an Adjunct Professor at the Department of Molecular Pharmaceutics, University of Utah, and the Nano Institute of Utah. He has held academic roles at various institutions, including the University of Utah in USA, the University of Otago in New Zealand, and Suez Canal University in Egypt. In 1992, he earned his MB.B. Ch with honors in Medicine and Surgery and a master’s degree in clinical Oncology in 1997 from the Faculty of Medicine, Suez Canal University. He acquired his Ph.D. in Targeted Anticancer Therapy from the Graduate School of Medical Sciences, Kumamoto University, Japan, in 2004. Greish has made significant contributions to the field of nanomedicine, with 120 papers published in various journals. These publications have garnered over 7800 citations, earning him an h-index of 41 (Scopus, April 2024). His research and specialties span nanomedicine, anticancer drug delivery, and tumor vascular biology.